GVS advice concerning romosozumab (Evenity®) for the treatment of severe osteoporosis
van der Waal JM, Wijma S
Record ID 32018001606
Dutch
Original Title:
GVS advice concerning romosozumab (Evenity®)
Authors' objectives:
GVS advice concerning romosozumab (Evenity®)
Details
Project Status:
Completed
Year Published:
2020
URL for published report:
https://english.zorginstituutnederland.nl/publications/reports/2020/12/16/gvs-advice-concerning-romosozumab-evenity
English language abstract:
An English language summary is available
Publication Type:
Full HTA
Country:
The Netherlands
MeSH Terms
- Fractures, Bone
- Bone Density
- Antibodies, Monoclonal
- Bone Density Conservation Agents
- Osteoporosis, Postmenopausal
- Osteoporosis
Contact
Organisation Name:
The National Health Care Institute (ZIN, Zorginstituut Nederland)
Contact Address:
Postbus 320, NL-1110 AH Diemen The Netherlands
Contact Name:
Timon Sibma
Contact Email:
TSibma@zinl.nl
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.